Eli Lilly & Company (NYSE:LLY) ranks among the best low volatility stocks to buy according to analysts. On July 11, ...

Researchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...

Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...

Eli Lilly and Company (NYSE:LLY) is experiencing a strong analyst sentiment amid its expanding role in cutting-edge ...

New research shows that most people regain weight after stopping Ozempic and similar weight-loss drugs around the eight-week ...

The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...

The incretin-based therapies reduced mortality and hospitalization risk in individuals with heart failure with preserved ...

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...

More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...